Press Release – New York, NY – February 5, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP Represents A2Z Cust2Mate Solutions Corp. in $30 Million Public Offering and Concurrent Registered Direct Offering
Press Release – New York, NY – January 29, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) (FRA - WKN: A3CSQ), a global leader …
Sichenzia Ross Ference Carmel LLP Represents Nvni Group in $12 Million Private Placement Offering
New York, NY - December 31, 2024 - Sichenzia Ross Ference Carmel LLP announced that it represented Nuvini Group Limited in its $12 million private placement offering. Maxim Group LLC acted as the …
Sichenzia Ross Ference Carmel LLP Represents A2Z Cust2Mate Solutions Corp. in $12.5 Million Registered Direct Offering
Press Release – New York, NY – December 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a global leader in innovative …
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.5 Million Public Offering
Press Release – New York, NY – December 12, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP represents Lexaria Bioscience Corp. in $5 Million Registered Direct Offering and Concurrent Private Placement
Press Release – New York, NY – October 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery …